Global healthcare company Abbott announced the launch of its latest generation XIENCE Sierra everolimus-eluting coronary stent system in India. This launch comes after the stent system received regulatory approval from India's Central Drugs Standard Control Organisation (CDSCO) in February 2023. The XIENCE Sierra is part of Abbott's family of drug-eluting...
Cardinal Health Partners with India's Sahajanand Medical Technologies
Dublin, Ohio-based Cardinal Health, Inc., announced a strategic partnership with Surat, India-based Sahajanand Medical Technologies . This partnership will provide Cardinal Health access to India's urban and Tier II & III cities where Sahajanand has strong and established sales as well as a direct distribution network. The Cordis unit of Cardinal Health plans...